We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Metabolon and SJTU Open Metabolomics Lab in China

Read time: Less than a minute

Metabolon, Inc. has announced that it has opened a new metabolomics lab in Shanghai, China in collaboration with Shanghai Jiao Tong University (SJTU).

The SJTU-Metabolon Joint Metabolomics Laboratory is a partnership with Shanghai Jiao Tong University, one of the oldest and most prestigious public research universities in China.

Metabolon has licensed its proprietary metabolomics platform technology to SJTU to enable a world class biochemical profiling laboratory at the university.

SJTU has funded the laboratory and personnel already trained by Metabolon and will work with academic and commercial scientists within China or other Asian countries to perform biochemical profiling experiments with Metabolon’s technology.

“We are very pleased to be bringing the science of metabolomics to a large untapped market such as China and the Asian continent as a whole,” said Metabolon president and CEO John Ryals, Ph.D.

Ryals continued, “Our partnership with Shanghai Jiao Tong University is further proof of Metabolon’s efforts to bring personalized medicine and metabolic biomarker research to all parts of the globe.”

“Metabolomics is an important field of study that holds great promise for plant biology, medical and nutrition needs,” said Shanghai Jiao Tong University spokesperson Professor Dabing Zhang.

Zhang continued, “We are excited to work with a company on the cutting edge of such promising healthcare technology.”

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.